FIELD: pharmaceutical industry. SUBSTANCE: described are particular physical forms of 5-acetamido-2,3,4,5-tetradeoxy-4-guanidino-3- glycero-D-galactonone-2-enopyranozonic acid, more particularly in crystalline form in which all crystalline water is substantially lost at 80-90 C, 5-acetamido, 2,3,4,5-tetradeoxy-4-guanidino-D-glycero-D-galactonone-2- enopyranozonic acid is included into pharmaceutical composition for use as antiviral agent. EFFECT: improved properties of the pharmaceutical composition. 33 cl, 1 dwg, 11 ex, 2 tbl
Authors
Dates
1999-08-20—Published
1994-12-15—Filed